Context Therapeutics Inc. (CNTX)
USD 1.22
(-5.43%)
USD 1.22
(-5.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | 12.04 Thousand | 9268.00 | - | - | - |
| Gross Profit | -12.04 Thousand | -9268.00 | - | - | - |
| Operating Expenses | 25.07 Million | 14.88 Million | 7.43 Million | 2.57 Million | 5.37 Million |
| Selling, General and Administrative Expenses | 7.28 Million | 7.79 Million | 3.63 Million | 930.66 Thousand | 2.96 Million |
| Research and Development Expenses | 17.78 Million | 7.09 Million | 3.8 Million | 1.64 Million | 2.41 Million |
| Other Expenses | - | -2004.00 | 123.87 Thousand | 9.87 Million | 93.36 Thousand |
| Cost and Expenses | 25.07 Million | 14.88 Million | 7.43 Million | 2.57 Million | 5.37 Million |
| Operating Income | -25.07 Million | -15.38 Million | -10.52 Million | -2.57 Million | -5.37 Million |
| Interest Expense | - | 547.26 Thousand | 64.24 Thousand | 661.22 Thousand | 1.1 Million |
| Income Tax Expense | - | -545.26 Thousand | -3.02 Million | 661.22 Thousand | 1.1 Million |
| Earnings before Tax | -23.96 Million | -14.83 Million | -10.45 Million | 6.64 Million | -6.38 Million |
| Net Income | -23.96 Million | -14.29 Million | -7.43 Million | 6.64 Million | -7.48 Million |
| Earnings Per Share Basic | -1.50 | -0.90 | -0.47 | 0.61 | -0.68 |
| Earnings Per Share Diluted | -1.50 | -0.90 | -0.47 | 0.61 | -0.68 |
| Weighted Average Shares Outstanding | 15.96 Million | 15.96 Million | 15.96 Million | 10.95 Million | 10.95 Million |
| Weighted Average Shares Outstanding (Diluted) | 15.96 Million | 15.96 Million | 15.96 Million | 10.95 Million | 10.95 Million |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -25.06 Million | -14.82 Million | -10.52 Million | - | - |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 18.95 Thousand | - | - | - |
| Cost of Revenue | 2568.00 | 2568.00 | 2568.00 | 12.04 Thousand | 3089.00 | 3194.00 |
| Gross Profit | -2568.00 | -2568.00 | 16.38 Thousand | -12.04 Thousand | -3089.00 | -3194.00 |
| Operating Expenses | 3.08 Million | 3.82 Million | 6.93 Million | 25.06 Million | 6.18 Million | 5.29 Million |
| Selling, General and Administrative Expenses | 1.7 Million | 1.84 Million | 1.62 Million | - | 1.69 Million | 1.83 Million |
| Research and Development Expenses | 1.38 Million | 1.97 Million | 5.3 Million | - | 4.48 Million | 3.46 Million |
| Other Expenses | -6107.00 | 3353.00 | -61.4 Thousand | - | 15.36 Thousand | -12.22 Thousand |
| Cost and Expenses | 3.08 Million | 3.82 Million | 6.93 Million | 25.07 Million | 6.18 Million | 5.29 Million |
| Operating Income | -3.08 Million | -3.82 Million | -6.93 Million | -25.07 Million | -6.18 Million | -5.29 Million |
| Interest Expense | - | - | 358.23 Thousand | - | - | - |
| Income Tax Expense | 2.00 | 2.00 | 2.00 | -4.00 | -290.44 Thousand | -293.27 Thousand |
| Earnings before Tax | -2.25 Million | -3.66 Million | -6.76 Million | -23.96 Million | -5.87 Million | -5.01 Million |
| Net Income | -2.25 Million | -3.66 Million | -6.76 Million | -23.96 Million | -5.87 Million | -5.01 Million |
| Earnings Per Share Basic | -0.04 | -0.23 | -0.42 | - | -0.37 | -0.31 |
| Earnings Per Share Diluted | -0.04 | -0.23 | -0.42 | - | -0.37 | -0.31 |
| Weighted Average Shares Outstanding | 54.95 Million | 15.96 Million | 15.96 Million | 15.96 Million | 15.96 Million | 15.96 Million |
| Weighted Average Shares Outstanding (Diluted) | 54.95 Million | 15.96 Million | 15.96 Million | 15.96 Million | 15.96 Million | 15.96 Million |
| Gross Margin | - | - | 0.86 | - | - | - |
| EBIT Margin | - | - | -365.69 | - | - | - |
| Profit Margin | - | - | -357.21 | - | - | - |
| EBITDA | -3.08 Million | -3.82 Million | -6.93 Million | - | -6.17 Million | -5.28 Million |
| Earnings Before Tax Margin | - | - | -365.83 | - | - | - |
002519
7991
002637
NIITLTD
000887
9587